.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L03A_Immunostimulants.L03AC02_Oprelvekin.Oprelvekin

Information

name:Oprelvekin
ATC code:L03AC02
route:subcutaneous
n-compartments1

Oprelvekin (recombinant interleukin-11) is a thrombopoietic growth factor used to stimulate the production of platelets in patients undergoing chemotherapy for non-myeloid malignancies. It was approved to reduce the incidence of severe thrombocytopenia and the need for platelet transfusions, but its use is limited due to safety concerns related to fluid retention and cardiac events.

Pharmacokinetics

Pharmacokinetic data in patients with cancer; typical population included adults administered subcutaneous oprelvekin after chemotherapy.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos